LIQUAMAR Drug Patent Profile
✉ Email this page to a colleague
When do Liquamar patents expire, and when can generic versions of Liquamar launch?
Liquamar is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in LIQUAMAR is phenprocoumon. Additional details are available on the phenprocoumon profile page.
Summary for LIQUAMAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Patent Applications: | 3,637 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LIQUAMAR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LIQUAMAR
US Patents and Regulatory Information for LIQUAMAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | LIQUAMAR | phenprocoumon | TABLET;ORAL | 011228-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |